Wilson’s disease

Showing 1 posts of 1 posts found.

Alexion $855m portfolio boost after Wilson Therapeutics buyout

April 11, 2018
Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical

Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …

Latest content